Merck KGaA: The DAX Giant Acquires Bio-Techne for $11 Billion and Simultaneously Accelerates the AI Chip Turbo.

In the DAX, Merck KGaA breaks out of the correction since 2022. Such a movement has high significance, which is why it is important to look at the reasons. The $11 billion coup: how Bio-Techne is transforming the life science sector On June 25, 2026, Merck made a takeover bid. For $73 per share in cash, or $11.3 billion in total, Bio-Techne is to be acquired. This secures Merck a portfolio driven by consumables, which accounts for 81% of Bio-Techne's total sales. The Americans are leaders in proteomics, spatial biology, and cell therapy. Through...